Phase 1 of DTP/Hepatitis B 10ug Hib Vaccine

NCT01977196 Phase 1 COMPLETED

The objective of this study was to know the safety of DTP/Hepatitis B and Hib/PRP-T vaccine and immediate reactions within the first 30 minutes after injection.

Details

Lead sponsor	PT Bio Farma
Phase	Phase 1
Status	COMPLETED
Enrolment	30
Start date	2011-04
Completion	2011-07

Conditions

• Healthy

Interventions

• DPT/HepatitisB/Hib vaccine

Primary outcomes

• Incidence rate of adverse event of DTP/Hepatitis B/Hib vaccine (Bio Farma) — 30 minutes
  Local and systemic reactions

Countries

Indonesia